• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未预防性应用诺氟沙星的肝硬化患者自发性细菌性腹膜炎复发:血清白蛋白是一个简单但可靠的预测因素。

Recurrence of spontaneous bacterial peritonitis in cirrhotic patients non-prophylactically treated with norfloxacin: serum albumin as an easy but reliable predictive factor.

机构信息

Department of Hepato-Gastroenterology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan, ROC.

出版信息

Liver Int. 2011 Feb;31(2):184-91. doi: 10.1111/j.1478-3231.2010.02377.x. Epub 2010 Dec 8.

DOI:10.1111/j.1478-3231.2010.02377.x
PMID:21143367
Abstract

BACKGROUND

Several large studies revealed that selective intestinal decontamination (SID) prevented recurrence of spontaneous bacterial peritonitis (SBP) in cirrhotic patients. Nonetheless, there are no definitive patient selection parameters identifying who would benefit from SID.

AIMS

To investigate long-term outcomes in cirrhosis patients with recurrence of SBP and to identify predictive factors for SBP recurrence.

METHODS

We retrospectively studied 146 cirrhosis patients diagnosed with a first episode of SBP from 2005 to 2006. Of these, 89 patients survived; the survivors were divided into two groups based on recurrence and non-recurrence of SBP, and clinical parameters, survival time and cause of death were analysed.

RESULTS

The in-hospital mortality was 39% (57/146). The SBP recurrence rate was 42.7% (38/89). The survival rate between patients with recurrent SBP and those without recurrence did not differ (P=0.092). Sepsis was the major cause of death in the recurrent SBP group, but not in the non-recurrent group. Serum albumin level before discharge and β-blocker use between the two groups differed significantly (P<0.0001). Using the cut-off point for serum albumin level before discharge of 2.85 g/dl as a predictor for recurrence of SBP, the sensitivity was 70.2% and the specificity was 76.3%. Furthermore, long-term survival of the group with high albumin before discharge was better than that of the corresponding group with low albumin (P=0.007).

CONCLUSION

Spontaneous bacterial peritonitis was associated with high sepsis-related mortality in cirrhotic patients. Serum albumin before discharge was a useful single parameter to predict the recurrence of SBP and long-term survival.

摘要

背景

几项大型研究表明,选择性肠道去污染(SID)可预防肝硬化患者自发性细菌性腹膜炎(SBP)的复发。然而,目前尚无确定的患者选择参数来确定谁将从 SID 中受益。

目的

探讨肝硬化患者 SBP 复发的长期预后,并确定 SBP 复发的预测因素。

方法

我们回顾性研究了 2005 年至 2006 年期间首次发生 SBP 的 146 例肝硬化患者。其中 89 例存活;根据 SBP 是否复发,将幸存者分为两组,并分析临床参数、生存时间和死亡原因。

结果

住院死亡率为 39%(57/146)。SBP 复发率为 42.7%(38/89)。复发 SBP 患者与未复发 SBP 患者的生存率无差异(P=0.092)。复发 SBP 组的主要死亡原因为感染性休克,而非复发 SBP 组则为非感染性休克。两组间出院前血清白蛋白水平和β受体阻滞剂的使用存在显著差异(P<0.0001)。以出院前血清白蛋白水平 2.85 g/dl 为截点预测 SBP 复发,其敏感性为 70.2%,特异性为 76.3%。此外,出院前白蛋白水平高的患者的长期生存率优于相应的低白蛋白组(P=0.007)。

结论

自发性细菌性腹膜炎与肝硬化患者感染性休克相关死亡率高有关。出院前血清白蛋白是预测 SBP 复发和长期生存的有用单一参数。

相似文献

1
Recurrence of spontaneous bacterial peritonitis in cirrhotic patients non-prophylactically treated with norfloxacin: serum albumin as an easy but reliable predictive factor.未预防性应用诺氟沙星的肝硬化患者自发性细菌性腹膜炎复发:血清白蛋白是一个简单但可靠的预测因素。
Liver Int. 2011 Feb;31(2):184-91. doi: 10.1111/j.1478-3231.2010.02377.x. Epub 2010 Dec 8.
2
Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.诺氟沙星连续预防与住院预防自发性细菌性腹膜炎首发发作的比较
Hepatology. 1997 Mar;25(3):532-6. doi: 10.1002/hep.510250306.
3
Is there yet any place for reagent strips in diagnosing spontaneous bacterial peritonitis in cirrhotic patients? An accuracy and cost-effectiveness study in Brazil.试剂条在诊断肝硬化患者自发性细菌性腹膜炎方面还有立足之地吗?巴西的一项准确性和成本效益研究。
J Gastroenterol Hepatol. 2008 Dec;23(12):1895-900. doi: 10.1111/j.1440-1746.2008.05571.x.
4
[Spontaneous bacterial peritonitis caused by Streptococcus milleri in a cirrhotic patient with selective intestinal decontamination].
Gastroenterol Hepatol. 1998 Jan;21(1):27-8.
5
Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.对细菌感染进行肠外抗生素预防并不能提高口服诺氟沙星对肝硬化合并胃肠道出血患者的成本效益。
Am J Gastroenterol. 1998 Dec;93(12):2457-62. doi: 10.1111/j.1572-0241.1998.00704.x.
6
[Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].[在接受选择性肠道去污的肝硬化患者粪便中对喹诺酮类耐药的大肠杆菌菌株的发展]
Med Clin (Barc). 1999 Sep 11;113(7):241-5.
7
Factors that predict recurrent spontaneous bacterial peritonitis in cirrhotic patients.预测肝硬化患者复发性自发性细菌性腹膜炎的因素。
Int J Clin Pract. 2020 Mar;74(3):e13457. doi: 10.1111/ijcp.13457. Epub 2019 Dec 17.
8
Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis.诺氟沙星选择性肠道去污对肝硬化动物模型中自发性细菌性腹膜炎、细菌移位及生存的影响
Hepatology. 1995 Jun;21(6):1719-24.
9
[Spontaneous bacterial peritonitis in liver cirrhosis with ascites].[肝硬化腹水患者的自发性细菌性腹膜炎]
Dtsch Med Wochenschr. 1995 Mar 31;120(13):454-60. doi: 10.1055/s-2008-1055366.
10
Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis.肝硬化患者的小肠细菌过度生长:患病率及其与自发性细菌性腹膜炎的关系。
Am J Gastroenterol. 2001 Oct;96(10):2962-7. doi: 10.1111/j.1572-0241.2001.04668.x.

引用本文的文献

1
Fluoroquinolones for the Prophylaxis of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis: Are They Losing Ground?氟喹诺酮类药物用于肝硬化患者自发性细菌性腹膜炎的预防:它们正在失宠吗?
Life (Basel). 2025 Apr 2;15(4):586. doi: 10.3390/life15040586.
2
A Validated Composite Score Demonstrates Potential Superiority to MELD-Based Systems in Predicting Short-Term Survival in Patients with Liver Cirrhosis and Spontaneous Bacterial Peritonitis-A Preliminary Study.一项经过验证的综合评分在预测肝硬化合并自发性细菌性腹膜炎患者短期生存方面显示出优于基于终末期肝病模型(MELD)系统的潜力——一项初步研究。
Diagnostics (Basel). 2023 Aug 2;13(15):2578. doi: 10.3390/diagnostics13152578.
3
Retrospective Investigation of Factors Affecting Mortality in Spontaneous Bacterial Peritonitis.
自发性细菌性腹膜炎死亡率影响因素的回顾性调查
Euroasian J Hepatogastroenterol. 2023 Jan-Jun;13(1):5-9. doi: 10.5005/jp-journals-10018-1387.
4
Use of albumin infusion for cirrhosis-related complications: An international position statement.白蛋白输注在肝硬化相关并发症中的应用:一项国际立场声明。
JHEP Rep. 2023 May 5;5(8):100785. doi: 10.1016/j.jhepr.2023.100785. eCollection 2023 Aug.
5
Bacteremia (Sepsis), Hepatorenal Syndrome, and Serum Creatinine Levels Rather than Types or Microbial Patterns Predicted the Short-Term Survival of Cirrhotic Patients Complicated with Spontaneous Bacterial Peritonitis.菌血症(脓毒症)、肝肾综合征及血清肌酐水平而非类型或微生物模式可预测肝硬化合并自发性细菌性腹膜炎患者的短期生存情况。
Diagnostics (Basel). 2022 Dec 28;13(1):94. doi: 10.3390/diagnostics13010094.
6
Use of human albumin infusion in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials.肝硬化患者人血白蛋白输注的应用:系统评价和随机对照试验的荟萃分析。
Hepatol Int. 2022 Dec;16(6):1468-1483. doi: 10.1007/s12072-022-10374-z. Epub 2022 Sep 1.
7
Factors Associated with Delayed Paracentesis in Patients with Spontaneous Bacterial Peritonitis.自发性细菌性腹膜炎患者延迟进行腹腔穿刺术的相关因素。
Dig Dis Sci. 2021 Nov;66(11):4035-4045. doi: 10.1007/s10620-020-06750-0. Epub 2020 Dec 3.
8
Initial choice of antibiotic in recurrent spontaneous bacterial peritonitis: A retrospective study.复发性自发性细菌性腹膜炎抗生素的初始选择:一项回顾性研究。
Int J Crit Illn Inj Sci. 2019 Oct-Dec;9(4):187-190. doi: 10.4103/IJCIIS.IJCIIS_49_18. Epub 2019 Dec 11.
9
Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death.肝硬化患者的细菌感染:别被细菌搞死。
Dig Dis Sci. 2020 Jan;65(1):31-37. doi: 10.1007/s10620-019-05943-6.
10
Association of serum albumin level with incidence and mortality of overt hepatic encephalopathy in cirrhosis during hospitalization.肝硬化患者住院期间血清白蛋白水平与显性肝性脑病发生率及死亡率的相关性
Therap Adv Gastroenterol. 2019 Oct 7;12:1756284819881302. doi: 10.1177/1756284819881302. eCollection 2019.